Introduction and and purpose of paper:
The aim of this paper was to present modern methods of treatment for endometriosis. Endometriosis is a chronic inflammatory condition of women that is characterized by the implementation of endometrial tissue outside the uterus. It affects 7 to 15% of menstruating women, and 35 to 50% of women treated for infertility.
State of knowledge:
Diagnosis of endometriosis is made on the basis of well-collected gynecological history, clinical examinations and imaging techniques. The golden standard for diagnostics is laparoscopy with subsequent histological examination of the material collected during the procedure. Among the methods of treatment in women with endometriosis, pharmacological and surgical treatment is applied. The pharmacological agents most commonly used in endometriosis are: combined hormonal contraceptives, progestins and anti-progestins, GnRH agonists and antagonists, aromatase inhibitors, Danazol and non-steroidal anti-inflammatory drugs (NSAIDs). Pharmacological treatment is only symptomatic, not cytoreductive, therefore, to remove endometriosis lesions, surgery should be performed. There are two ways to perform surgery: laparotomy and laparoscopy. Surgical treatment of endometriosis may be associated with local excision of lesions and sometimes even removal of the entire organ. Treatment should be conducted in consultation with the patient and her wishes. Conservative treatment is most commonly used among women of reproductive age.
Summary:
The pharmaceutical or surgical treatment require an individual approach and deliberated informed consent of patient. Pharmacological treatment is only symptomatic, not cytoreductive, therefore, to remove endometriosis lesions, surgery should be performed.

endometriosis; treatment; pelvic pain; infertility

Kotarski J, Skrzypczak J. Endometrioza. [Endometriosis] W: Bręborowicz G. (red.). Położnictwo i ginekologia [Obstetrics and gynecology]. Warszawa: PZWL; 2014: 875-886 (in Polish).

Brucka A, Górski J, Kulig B. (2012). Stanowisko Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego dotyczące diagnostyki i metod leczenia endometriozy. [The position of the Panel of Experts of the Polish Gynecological Society regarding diagnostics and methods of treatment of endometriosis.] Ginekol Pol, 2012, 83, 871-876 (in Polish).

Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014 Mar;29(3):400-12.

Collinet P, Fritel X, Revel-Delhom C, Ballester M, Bolze PA, Borghese B, ... & Chauffour C. Management of endometriosis CNGOF/HAS clinical practice guidelines short version. J Gynecol Obstet Hum Reprod. 2018 Sep;47(7):265-274

Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993; 60: 75–79.

Jensen JT, Schlaff W, Gordon K. The use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence. Fertil Steril. 2018 Jul 1;110(1):137-152

Becker CM, Gattrell WT, Gude K, Singh S.S. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril 2017;108:125–36.

Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2012; 3:CD002122.

Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008475

Makarainen L, Ronnberg L, Kauppila A. Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis. Fertil Steril 1996;65:29–34.

Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000068.

Hart RJ, Hickey M, Maouris P, Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004992.

Carmona F, Martinez-Zamora MA, Rabanal A, Martinez-Roman S, Balasch J. Ovarian cystectomy versus laser vaporization in the treatment of ovarian endometriomas: a randomized clinical trial with a five-year follow-up. Fertil Steril 2011; 96:251–254.

Mira T A, Buen MM, Borges MG, Yela DA, Benetti‐Pinto CL. Systematic review and meta‐analysis of complementary treatments for women with symptomatic endometriosis. International Journal of Gynecology & Obstetrics, 143(1), 2-9.

Mosher AA, Tsoulis MW, Lim J, Tan C, Agarwal SK, Leyland NA, Foster WG. Melatonin activity and receptor expression in endometrial tissue and endometriosis. Human Reproduction 2019

Zhang L, Zhang X. Research progress on roles of vitamin D in endometriosis. Zhejiang da xue xue bao. Yi xue ban= Journal of Zhejiang University. Medical sciences, 2018, 47.4: 413-418.

Ata B, Yildiz S, Turkgeldi E, Brocal VP, Dinleyici EC, MoyaA, Urman B. The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls. Scientific reports, 9(1), 2204.